Vagus Nerve Stimulation and Stress Reduction Training for Migraine
Part of paid clinical trials in Charlestown, Massachusetts.
- Sponsor
- Massachusetts General Hospital
- Study ID
- NCT03592329
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Stress Reduction Training A — BEHAVIORALtwice weekly "booster" sessions and weekly instructor-led sessions for 8 weeks plus home practice sessions
- active tVNS — DEVICEnon-painful electrical stimulation of the auricle
- Stress Reduction Training B — BEHAVIORALtwice weekly "booster" sessions and weekly instructor-led sessions for 8 weeks plus home practice sessions
- sham tVNS — DEVICEsham stimulation
Study Details
This study design has two components: 1) a cross-sectional assessment of brain activity and inflammation in migraine patients compared to healthy controls and 2) an assessment of 8 weeks of a combination therapy approach to treating migraine.
Key Dates
- Start date
- Aug 20, 2019
- Status verified
- Feb 2026
- Primary completion
- Jan 14, 2025
- Completion
- May 29, 2025
Study Design
- Enrollment
- 193 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: active tVNS + SRT Aactive tVNS and Stress Reduction Training A
- Experimental: active tVNS + SRT Bactive tVNS and Stress Reduction Training B
- Other: sham tVNS + SRT Asham stimulation and Stress Reduction Training A
- Other: sham tVNS + SRT Bsham tVNS and Stress Reduction Training B
Primary Outcome Measure
Brain Activity Changes in Migraine Patients in Response to Treatment [ Time Frame: 8 weeks (i.e. post-treatment) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Anthinoula A. Martinos Center | Charlestown | Massachusetts | 02129 | - |
Find similar trials in Charlestown, MA
By condition
By specialty
By research site
Related Studies
- BE WELL With Migraine: Brain Education and WELLness With MigraineRecruiting · Wake Forest University Health Sciences · Cambridge, Massachusetts
- Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual MigrainePHASE3 · Recruiting · AbbVie · Birmingham, Alabama
- A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent MigrainePHASE3 · Recruiting · Pfizer · Phoenix, Arizona
- Cocoa Extract for Migraine TrialRecruiting · Brigham and Women's Hospital · Boston, Massachusetts